市场调查报告书
商品编码
1383423
到 2030 年色谱设备市场预测:按类型、配件/消耗品、最终用户和地区进行全球分析Chromatography Instruments Market Forecasts to 2030 - Global Analysis By Type, By Accessory & Consumable, End User and By Geography |
根据Stratistics MRC的数据,2023年全球色谱设备市场规模为105.6亿美元,预计到2030年将达到170.7亿美元,预测期内年复合成长率为7.1%。
色谱设备是一种用于分离和鑑定混合物中组分的分析工具。它的工作原理是差速传输,其中样品化合物以不同的速度通过固定相,从而实现分离和分析。这些仪器对于化学、製药、环境科学和生物化学等各个领域的复杂混合物的表征和定量至关重要。
根据《世界製药科学杂誌》报道,全球 78% 以上的化学分析是在色谱仪器上进行的。
色谱法已得到广泛认可,在药物研究、环境分析以及食品和饮料行业中发挥着至关重要的作用。色谱法以高精度和高灵敏度分离和分析复杂混合物的能力现在至关重要。随着各行业不断寻求产品品质、安全性和法规遵从性的改进,色谱仪器在药物开发、品管和环境监测等应用中的需求量很大,并作为各个领域的重要分析工具进行销售。支持成长
色谱设备的高成本是色谱设备市场的主要抑制因素。这些设备技术先进,需要精密工程,导致製造成本高。因此,许多实验室,特别是在资源有限的环境中,面临预算限制,这可能会阻止他们投资或升级色谱设备。此外,消耗品、维护和操作所需的专业知识等成本也会增加总成本。
对石化产品日益增长的需求增加了对精确、高效的分析工具的需求,以评估产品品质、纯度以及对环境法规的遵守情况。气相层析管技术的进步,包括高温稳定性、增强的分离能力和改进的耐用性,使得复杂碳氢化合物混合物的分析更加准确和快速。这支持了石化产业对产品最佳化、成本效率和合规性的追求,从而推动了对色谱设备的需求。
儘管色谱法是一种被广泛接受且有效的分离技术,但质谱法和核磁共振波谱法等替代技术也越来越受到重视,特别是对于复杂样品的分析。这些替代方案提供不同的功能,并且对于特定应用具有竞争。随着技术的发展,色谱法面临日益激烈的竞争的风险,迫使该行业进行创新和适应。
COVID-19大流行对市场产生了中等影响。全球危机扰乱了供应链并推迟了色谱设备和消耗品的生产和分销。它也导致非必要的研究和工业流程暂时放缓,影响了需求。然而,这场大流行凸显了色谱在医疗保健、诊断和药物研究中的重要性,导致对测试和药物开发的需求增加。总体而言,虽然最初的破坏很困难,但这场大流行最终凸显了色谱设备在应对公共卫生和科学挑战方面的重要作用。
液相层析系统部分预计将占据市场上最大的市场占有率。这项预测主要归因于液相层析的多功能性、高解析度以及对多种行业的适用性,包括製药、生物技术、环境分析以及食品和饮料。液相层析可以精确分离和定量化合物,这对于药物开发、品管和研究至关重要。此外,高效液相层析(HPLC)和超高效液相层析(UHPLC)等液相层析技术的进步进一步增强了其市场主导地位。
生命科学产业有望在市场中实现显着成长。这种成长的关键驱动因素是色谱在製药、生物技术和临床研究中的使用不断增加。色谱在药物开发、品管和生物分子分析中发挥重要作用,特别是在生物製药和个人化医疗日益增长的需求中。此外,基因组学、蛋白质组学和代谢组学研究对精密分析工具的需求进一步推动了生命科学中色谱设备的采用。
北美拥有许多大型製药企业、研究机构和临床实验室,广泛使用色谱法进行药物研发、品管和生物分子分析,使其成为预测期内最大的市场,预计将占据很大份额。此外,医疗保健和生命科学领域严格的法规要求正在推动对精密分析设备的需求。此外,对研发的持续关注和完善的医疗基础设施正在支持该地区的成长。
亚太地区预计将出现显着的市场成长。该地区的製药和生技产业快速成长,研发投入不断增加。此外,新兴国家工业化和都市化的不断发展进一步推动了对环境监测和分析的需求,增加了市场未来性。随着亚太地区不断发展成为科学和工业发展中心,色谱设备的采用预计将大幅增加。
According to Stratistics MRC, the Global Chromatography Instruments Market is accounted for $10.56 billion in 2023 and is expected to reach $17.07 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Chromatography instruments are analytical tools used for separating and identifying components within a mixture. They operate on the principle of differential migration, where sample compounds move at different rates through a stationary phase, allowing for separation and analysis. These instruments are essential in various fields, including chemistry, pharmaceuticals, environmental science, and biochemistry, to characterize and quantify complex mixtures.
According to the World Journal of Pharmaceutical Sciences, over 78% of chemical analysis is done by chromatography instruments globally.
Chromatography has gained widespread recognition for its pivotal role in pharmaceutical research, environmental analysis, and the food and beverage industry. Its ability to separate and analyze complex mixtures with high precision and sensitivity has become indispensable. As industries continuously seek to improve product quality, safety, and regulatory compliance, chromatography instruments are in high demand for applications like drug development, quality control, and environmental monitoring, fueling the market's growth as a critical analytical tool for various sectors.
The high cost of chromatography equipment serves as a significant restraint in the chromatography instrument market. These instruments are technologically advanced and require precision engineering, which results in substantial manufacturing expenses. As a result, many laboratories, especially in resource-constrained settings, may face budget limitations that hinder their ability to invest in or upgrade chromatography equipment. Additionally, the cost of consumables, maintenance, and expertise required for operation adds to the overall expenses.
With the increasing demand for petrochemical products, there's a growing need for precise and efficient analytical tools to assess product quality, purity, and compliance with environmental regulations. Advances in GC column technologies, including high-temperature stability, enhanced separation capabilities, and improved durability, enable more accurate and rapid analysis of complex hydrocarbon mixtures. This, in turn, supports the petrochemical industry's pursuit of product optimization, cost-efficiency, and compliance, driving the demand for chromatography instruments.
While chromatography is a widely accepted and effective separation technique, alternative methods, such as mass spectrometry and NMR spectroscopy, are gaining prominence, especially in the analysis of complex samples. These alternatives offer different capabilities and can compete in specific applications. As technology evolves, there is a risk of chromatography facing increased competition, compelling the industry to innovate and adapt.
The COVID-19 pandemic had a moderate impact on the market. The global crisis disrupted supply chains, leading to delays in the production and distribution of chromatography equipment and consumables. It also caused a temporary slowdown in non-essential research and industrial processes, affecting demand. However, the pandemic underscored the critical importance of chromatography in healthcare, diagnostics, and pharmaceutical research, leading to increased demand for testing and drug development. Overall, while the initial disruptions were challenging, the pandemic ultimately highlighted the indispensable role of chromatography instruments in addressing public health and scientific challenges.
The liquid chromatography systems segment is expected to capture the largest market share in the market. This projection is primarily due to the versatility, high resolution, and broad applicability of liquid chromatography in a wide range of industries, including pharmaceuticals, biotechnology, environmental analysis, and food and beverage. Liquid chromatography offers precise separation and quantification of compounds, making it indispensable in drug development, quality control, and research. Additionally, advancements in liquid chromatography techniques, such as high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC), have further fueled its dominance in the market.
The Life Sciences segment is poised for significant growth in the market. This growth is primarily driven by the expanding applications of chromatography in pharmaceuticals, biotechnology, and clinical research. Chromatography plays a vital role in drug development, quality control, and biomolecule analysis, especially with the rising demand for biopharmaceuticals and personalized medicine. Additionally, the need for precise analytical tools for genomics, proteomics, and metabolomics research further propels the adoption of chromatography instruments in life sciences.
North America is expected to secure the largest market share in the market during the forecast period owing to the region's robust presence of major pharmaceutical and biotechnology companies, research institutions, and clinical laboratories, all of which heavily rely on chromatography for drug discovery, quality control, and biomolecule analysis. Moreover, stringent regulatory requirements in the healthcare and life sciences sectors drive the demand for precise analytical instrumentation. In addition, continuous emphasis on research and development, coupled with a well-established healthcare infrastructure, is fueling the growth in this region.
Asia Pacific is poised to experience substantial growth in the market. The region is witnessing a burgeoning pharmaceutical and biotechnology industry, along with increasing investments in research and development. Additionally, the expanding industrialization and urbanization in emerging economies are further fueling the need for environmental monitoring and analysis, enhancing the market's prospects. As Asia Pacific continues to evolve as a hub for scientific and industrial advancement, the adoption of chromatography instruments is expected to rise significantly.
Some of the key players in Chromatography Instruments Market include: Agilent Technologies Inc., Bio-rad, Centurion Scientific, Chromatotec, Falcon Analytical Systems & Technologies, LLC, GE Healthcare, GL Sciences, Inc., Jasco, Inc., Leco Corporation, Merck KGAA, Novasep Holding SAS, OI Corporation, Pall Corporation, Perkinelmer, Inc., Phenomenex, Inc., Restek Corporation, Scion Instrument, Shimadzu Corporation, Skyray Instrument, Sri Instrument, Thermo Fisher Scientific Inc., Trajan Scientific and Medical Pty Ltd., Valco Instrument Company Inc. and Waters Corporation.
In August 2023, Waters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors. The new Waters™ XBridge™ Premier GTx BEH™ SEC columns doubles the speed of measuring the potency and safety of AAVs. Combining the columns with light scattering technologies from its Wyatt Technology portfolio deepens the level of information acquired from a single experiment and optimizes the manufacturing of these novel gene delivery vehicles.
In July 2023, Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of its PurePep® EasyClean (PEC) Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
In May 2023, Waters Corporation has successfully acquired Wyatt Technology, a leading provider of light scattering and field-flow fractionation instruments, software, accessories, and services. This acquisition strengthens Waters' position in bioanalytical characterisation for emerging areas such as cell and gene therapies, which offer substantial growth opportunities. By combining Wyatt's complementary analytical technologies with Waters' global presence and expertise in simplifying complex techniques, the company is better equipped to meet the increasing demands of its customers worldwide.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.